2020 Electronic Voting

Dear ESOI members,

Due to this year’s postponement of the ESOI annual meeting, the Oncologic Imaging Course, the annual General Assembly needs to be organised differently. There will be no face-to-face General Assembly, but all points which require a voting will be done electronically.

All full members in good standing having paid their membership fees for 2020 shall have the right to vote. These members will receive the e-mail with the voting link and login details on Monday, August 17.


Voting period

Start: Monday, August 17, 12:00 CEST
End: Monday, August 31, 23:59 CEST


Voting points

1. Approval of the membership fees 2021
The ESOI Executive Board proposes the membership fees for 2021 as following:
Full Members 50.00 Euro
Allied Science Member 50.00 Euro
Resident Member 25.00 Euro

2. Change of statutes
Statutes shall be amended as following:
7.Rights and duties of members
7.2 Only full members in good standing having paid their membership fees and all arrears shall have a vote in the General Assembly and shall be entitled to stand for office.

to be changed to:
7.2 Only full members in good standing having paid their membership fees and all arrears shall have a vote in the General Assembly. Only full members in good standing having paid their membership fees and all arrears, who are predominantly active in Europe (as decided by executive board) and/or with a European passport are eligible to stand for office.


  • If you have not yet renewed your membership for 2020, please do so at your earliest convenience but no later than Sunday, August 16.
  • We will be using the secure voting system Polyas.
  • Please check your e-mail address for correctness > ESOI Members Area
  • If you are a full member but do not receive an invitation e-mail on Monday, August 17, please first check your spam folder or contact the ESOI Office.


The result of the voting will be announced within September 2020.

If you have any questions, please do not hesitate to contact us.

About ESOI

The main goal of the society is to raise the scientific level and professional knowledge within the field of oncologic imaging and has thereby two important missions.

First, the society strives to globally provide high-quality education in cancer imaging and research – not only in countries with but also in those without access to high quality oncological education.

Second, ESOI aims to become an oncologic imaging society that will attract not only radiologists but everyone working in the field of oncology. There is no doubt that, for an optimal treatment outcome, the input of radiologists in the multidisciplinary approach is crucial.

Furthermore, it will be more important than ever to understand the questions from our oncological clinical partners, which are increasingly complex.

ESOI recognises these needs and strives to create an international platform that will bring together radiologists with clinical professionals such as surgical oncologists, medical oncologists, radiation oncologists and basic scientists in immunology, genetics, molecular pathology, biotechnology etc.

The ESOI board and I would very much welcome you as our colleague who would like to participate or be involved in ESOI’s activities and contribute to the exciting new developments in oncologic imaging.

Prof. Dr. Regina Beets-Tan
on behalf of the ESOI Executive Board

Vision & Mission


The European Society of Oncologic Imaging is an apolitical, non-profit organisation, exclusively and directly dedicated to promoting and coordinating the scientific, philanthropic, intellectual and professional activities of oncologic imaging. The Society’s mission at all times is to serve the health care needs of the general public through the support of science, teaching and research and the quality of service in the field of oncologic imaging.

The European Society of Oncologic Imaging will set its focus on establishing oncologic imaging (OI) as an area of special interest and expertise in the field of diagnostic and interventional radiology with the European Society of Radiology (ESR) and particularly with all established committees of ESR in order to provide both a scientific forum and to promote research as well as technical developments in oncologic imaging in Europe.

Through dissemination of knowledge and research information, in particular across Europe, the European Society of Oncologic Imaging aims to advance and improve all radiological aspects of patients with malignancy, the quality of diagnosis and treatment of oncologic patients by means of medical imaging.

ESOI Mission Statement

  •  The mission of ESOI is to promote advances in imaging and research activities related to cancer imaging.
  • The society is founded under the umbrella of ESR and shall be connected to ESR as an institutional member.
  • The society will closely cooperate with other European Imaging subspecialty societies, like ESGAR, ESUR, ESTI, ESHNR, CIRSE and will participate in the Subspecialty and Allied Sciences Committee and all other relevant committees of ESR.
  • ESOI aims to complement and enhance the activities of other existing societies as named above in relation to cancer imaging. It is not aimed at replacing any existing structure or society.
  • ESOI will aim to collaborate with key organisations in the field of cancer management and research e.g. EORTC.
  • ESOI will strive towards a multidisciplinary approach with representation from diagnostic and interventional radiology, nuclear medicine, radiation therapy, surgery, medical and clinical oncology, and engage other non-imaging societies, like ECO and ESMO both in terms of an educational programme and membership.
  • ESOI will aim to build an alliance with other international societies in the field of oncology and imaging, like the International Cancer Imaging Society (ICIS) to facilitate the collaboration in research and education activities.
  • ESOI will be open to medical professionals from radiology as well as clinical specialties and allied sciences; oncologists and oncologic surgeons as well as nuclear medicine physicians and radiotherapists will be encouraged to become members of ESOI.
  • ESOI will seek partnership with sponsors from both the radiological field and pharmaceutical/therapeutic companies, thereby enhancing its multidisciplinary approach to cancer management.
  • ESOI will ultimately aim to become a widely visible and highly recognized cancer imaging society that will attract not only radiologists but also surgical, medical oncology and radiotherapy specialists and allied scientists. We should embrace clinicians and they should have the desire to be part of our society with both sides ultimately benefiting from mutual education and cooperative research.
  • At ESOI meetings radiologists both attendees and faculties should be able to interact with clinicians and vice versa. Educational programmes should consist of lively discussion and debates.


Executive Board 2019-2021

Executive Board Members 2019-2021

Andrea Laghi, Rome/IT

Regina Beets-Tan, Amsterdam/NL

Heinz Peter Schlemmer, Heidelberg/DE

Chair Education Committee
Melvin D’Anastasi, Msida/MT

Chair Membership & Communication Committee
Laure Fournier, Paris/FR

Chair Research Committee
Emanuele Neri, Pisa/IT

Chair Young Radiologists Committee
Damiano Caruso, Rome/IT

Executive Board Members 2019-2021

Sofia Gourtsoyianni, Athens/GR

Tobias Bäuerle, Erlangen/DE

Member at Large
Julien Dinkel, Munich/DE

Member at Large
Ralf-Thorsten Hoffmann, Dresden/DE

Member at Large
Marius Mayerhöfer, Vienna/AT

Member at Large
Daniele Regge, Turin/IT

Committee Members 2019-2021


Education Committee 2019-2021

Melvin D’Anastasi, Msida/MT

Clemens Cyran,  Munich/DE

Anna Rita Larici, Rome/IT
Laura Martincich, Turin/IT
Stephanie Nougaret, Montpellier/FR
Vassiliki Pasoglou, Brussels/BE
Panos Prassopoulos, Alexandroupoli/GR
Davide Prezzi, London/UK
Irina Trofimenko, Moscow/RU
Giulia Zamboni, Verona/IT

Membership & Communication Committee 2019-2021

Laure Fournier, Paris/FR

Lukas Abraszek, Warsaw/PL
Tommaso Vincenzo Bartolotta, Palermo/IT
Olga Kucheruk, Moscow/RU
Max Lahaye, Amsterdam/NL
Bagyam Raghavan, Chennai/IN
Jens van Rensburg, Capetown/ZA

Research Committee 2019-2021

Emanuele Neri, Pisa/IT

Moritz Albrecht, Frankfurt am Main/DE
Michela Gabelloni, Minucciano/IT
Vicky Goh, London/UK
Andreas Hoetker, Zurich/CH
Monique Maas, Amsterdam/NL
Evis Sala, Cambridge/UK
Sikandar Shaikh, Hyderabad/IN
Vincent Vandecaveye, Leuven/BE

Young Radiologists Committee 2019-2021

Damiano Caruso, Rome/IT

Lucian Beer, Cambridge/UK
Tommaso Biondi, Belvedere Marittimo/IT
Alessandra Borgheresi, Sesto Fiorentino/IT
Giovanni Cappello, Turin/IT
Domenico De Santis, Rome/IT
Valeria Maria Doronzio, Turin/IT
Zuhir Elkarghali, Amsterdam/NL
Maurits Engbersen, Amsterdam/NL
Pavel Gelezhe, Moscow/RU
Sergio Grosu, Munich/DE
Philipp Kazmierczak, Munich/DE
Wolfgang Kunz, Munich/DE
Doris Leithner, Frankfurt am Main/DE
Daniel Paech, Heidelberg/DE
Ariadna Paliichuk, Kiev/UA
Elisa Rosati, Rome/IT
Carlotta Rucci, Rome/IT
Marta Zerunian, Rome/IT

Other Representatives & Organs 2019-2021


ESOI Representatives at ESR 2019-2021

ESR Subspecialties and Allied Sciences Committee
Andrea Laghi, Rome/IT

ESR Education Committee
Melvin D’Anastasi, Msida/MT

ESR Quality, Safety and Standards Committee
Sofia Gourtsoyianni, Athens/GR

ESR Research Committee
Vincent Vandecaveye, Leuven/NL

ESOI Controllers 2019-2021

Controller 1 
Christoph Mayer, Vienna/AT

Controller 2 
Georg Varga, Vienna/AT


The statutes of the European Society of Oncologic Imaging can be downloaded/viewed here:
ESOI Statutes